DRUP logo

DRUP
GraniteShares Nasdaq Select Disruptors ETF

78
Loading...
Loading...
News
all
press releases
News Placeholder
This Pharma Stock Soared 36% Today And Drew Price Target Hikes From Wall Street – More Details Inside
The company reported that Tyvaso demonstrated superiority over the placebo in terms of the change in absolute forced vital capacity, increasing by 95.6 mL from baseline to week 52 in patients with idiopathic pulmonary fibrosis in the trial.
Stocktwits·1mo ago

Latest DRUP News

View

Advertisement|Remove ads.

Advertisement|Remove ads.